Product Name

  • Name

    Famciclovir

  • EINECS 630-411-6
  • CAS No. 104227-87-4
  • Article Data31
  • CAS DataBase
  • Density 1.4 g/cm3
  • Solubility
  • Melting Point 102-104 °C
  • Formula C14H19N5O4
  • Boiling Point 550.2 °C at 760 mmHg
  • Molecular Weight 321.336
  • Flash Point 286.6 °C
  • Transport Information
  • Appearance off-white powder
  • Safety 36/37/39-45-53
  • Risk Codes 20/21/22-45-61
  • Molecular Structure Molecular Structure of 104227-87-4 (Famciclovir)
  • Hazard Symbols ToxicT
  • Synonyms Amciclovir;BRL 42810;[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate;FCV;1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester);2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester);Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine;Famvir;1,3-Propanediol,2-[2-(2-amino-9H-purin-9- yl)ethyl]-,diacetate (ester);Butenafine Hydrochloride;Famcyclovir;
  • PSA 122.22000
  • LogP 1.12220

Synthetic route

acetic anhydride
108-24-7

acetic anhydride

6-deoxypenciclovir
104227-86-3

6-deoxypenciclovir

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With pyridine; dmap In tetrahydrofuran at 20℃; for 3h;97%
With triethylamine In dichloromethane at 20 - 30℃; for 10h;90%
With pyridine; dmap In tetrahydrofuran for 3h; Ambient temperature;74%
Stage #1: 6-deoxypenciclovir With hydrogenchloride In water at 45 - 50℃; for 1.5h;
Stage #2: With triethylamine In dichloromethane at 22 - 30℃; for 0.166667 - 0.25h;
Stage #3: acetic anhydride With dmap In dichloromethane at 8 - 11℃; for 2.66667 - 2.75h;
With dmap; triethylamine In dichloromethane at 20℃; for 12h;
2-(2-((2-amino-6-chloro-5-nitrosopyrimidine-4-yl)amino)ethyl)propane-1,3-diol

2-(2-((2-amino-6-chloro-5-nitrosopyrimidine-4-yl)amino)ethyl)propane-1,3-diol

acetic anhydride
108-24-7

acetic anhydride

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Stage #1: 2-(2-((2-amino-6-chloro-5-nitrosopyrimidine-4-yl)amino)ethyl)propane-1,3-diol With 5%-palladium/activated carbon; ammonium formate In ethyl acetate at 65℃; for 22h;
Stage #2: orthoformic acid triethyl ester With acetic acid In ethyl acetate at 30℃; for 20h;
Stage #3: acetic anhydride With dmap; triethylamine In ethyl acetate at 30℃; for 1.5h; Reagent/catalyst; Temperature;
92.12%
9-<4-acetoxy-3-(acetoxymethyl)butyl>-2-amino-6-<(4-chlorophenyl)sulfanyl>-9H-purine
225111-66-0

9-<4-acetoxy-3-(acetoxymethyl)butyl>-2-amino-6-<(4-chlorophenyl)sulfanyl>-9H-purine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With nickel In ethanol; water for 1h; Heating;91%
acetic anhydride
108-24-7

acetic anhydride

2-amino-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine hydrochloride

2-amino-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine hydrochloride

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Stage #1: 2-amino-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine hydrochloride With triethylamine In dichloromethane at 10 - 20℃;
Stage #2: acetic anhydride With dmap In dichloromethane at 5 - 20℃;
91%
With dmap; triethylamine In dichloromethane at 20℃; for 2h; Acetylation;80%
Stage #1: 2-amino-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine hydrochloride With triethylamine In dichloromethane at 10 - 20℃; for 0.25 - 0.333333h;
Stage #2: acetic anhydride With dmap In dichloromethane at 5 - 20℃; for 3h;
6-deoxypenciclovir
104227-86-3

6-deoxypenciclovir

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With pyridine; dmap; acetic anhydride In tetrahydrofuran; methanol91%
9-<4-acetoxy-3-(acetoxymethyl)butyl>-2-amino-6-chloro-9H-purine
97845-60-8

9-<4-acetoxy-3-(acetoxymethyl)butyl>-2-amino-6-chloro-9H-purine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With water; ammonium formate; palladium on charcoal In ethyl acetate for 2h; Product distribution / selectivity;90.9%
With ammonium formate; palladium In methanol; water90%
With ammonium formate; palladium 10% on activated carbon In methanol for 2h; Heating / reflux;90%
acetic anhydride
108-24-7

acetic anhydride

diethyl 2-(2-(2-aminopurine-9-yl)ethyl)malonate
122497-22-7

diethyl 2-(2-(2-aminopurine-9-yl)ethyl)malonate

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
With pyridine; dmap; sodium tetrahydroborate Yield given. Multistep reaction;
2-amino-7-benzyl-1H-purin-6(7H)-one
17495-12-4

2-amino-7-benzyl-1H-purin-6(7H)-one

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 93 percent / 1-methyl-pyrrolidin-2-one / 1 h / 150 °C
2: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
3: HCOONH4 / Pd/C / methanol / 4 h / Heating
4: aq. NaOH / 0.5 h / Heating
5: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
6: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
7: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
8: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
9: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
N2-acetyl-7-benzylguanine
17495-10-2

N2-acetyl-7-benzylguanine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
2: HCOONH4 / Pd/C / methanol / 4 h / Heating
3: aq. NaOH / 0.5 h / Heating
4: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
5: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
6: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
7: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
8: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
N-(6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide
19962-37-9

N-(6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 12.6 g / 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
2.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
2.2: NH4OH / 1 h / Heating
3.1: 93 percent / 1-methyl-pyrrolidin-2-one / 1 h / 150 °C
4.1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
5.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
6.1: aq. NaOH / 0.5 h / Heating
7.1: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
8.1: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
9.1: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
10.1: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
11.1: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 12 steps
1.1: 1-methyl-pyrrolidin-2-one / 4 h / 150 °C
2.1: 12.6 g / 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
3.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
3.2: NH4OH / 1 h / Heating
4.1: 93 percent / 1-methyl-pyrrolidin-2-one / 1 h / 150 °C
5.1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
6.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
7.1: aq. NaOH / 0.5 h / Heating
8.1: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
9.1: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
10.1: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
11.1: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
12.1: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: 1.) trifluoroacetic anhydride / 1) pyridine, 0 deg C, 20 min; 2) pyridine, rt, 2 h
2: potassium carbonate / dimethylformamide / 18 h / 40 °C
3: 91 percent / Raney nickel / ethanol; H2O / 1 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: 1.) trifluoroacetic anhydride / 1) pyridine, 0 deg C, 20 min; 2) pyridine, rt, 2 h
2: 86.6 percent / potassium carbonate / dimethylsulfoxide / 1 h / 50 °C
3: 93 percent / potassium carbonate / dimethylsulfoxide / 1.5 h / 50 °C
4: 85 percent / NaBH4 / methanol; bis-(2-methoxy-ethyl) ether / 18 h / 50 °C
5: 96 percent / pyridine / 16 h / Ambient temperature
6: 91 percent / Raney nickel / ethanol; H2O / 1 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: trichlorophosphate / N,N-dimethyl-formamide / 6 h / 0 °C / Reflux
2: triphenylphosphine; diethylazodicarboxylate / tetrahydrofuran / 12 h / 70 °C / Inert atmosphere
3: potassium carbonate / dimethyl sulfoxide / 4 h / 40 - 50 °C
4: palladium 10% on activated carbon; hydrogen; triethylamine / methanol / 7 h / 55 °C
5: methanol; sodium tetrahydroborate / dichloromethane / 2.5 h / 20 °C
6: dmap; triethylamine / dichloromethane / 12 h / 20 °C
View Scheme
Penciclovir
39809-25-1

Penciclovir

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
2: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
3: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
4: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
5: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: dimethylsulfoxide / 24 h / 20 °C
1.2: 85 percent / aq. HCl / dimethylsulfoxide / 2 h / 70 °C
2.1: 93 percent / 1-methyl-pyrrolidin-2-one / 1 h / 150 °C
3.1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
4.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
5.1: aq. NaOH / 0.5 h / Heating
6.1: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
7.1: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
8.1: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
9.1: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
10.1: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
2-[(acetyloxy)methyl]-4-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)butyl acetate
97845-72-2

2-[(acetyloxy)methyl]-4-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)butyl acetate

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: aq. NaOH / 0.5 h / Heating
2: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
3: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
4: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
5: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
6: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
N2-acetyl-9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]guanine
256945-18-3

N2-acetyl-9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]guanine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
2: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
3: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
4: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
4-acetoxy-3-acetoxymethylbut-1-yl tosylate

4-acetoxy-3-acetoxymethylbut-1-yl tosylate

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
2: HCOONH4 / Pd/C / methanol / 4 h / Heating
3: aq. NaOH / 0.5 h / Heating
4: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
5: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
6: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
7: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
8: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
acetic acid 2-acetoxymethyl-4-(2-acetylamino-purin-9-yl)-butyl ester

acetic acid 2-acetoxymethyl-4-(2-acetylamino-purin-9-yl)-butyl ester

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
2: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-acetylamino-6-(2',4',6'-triisopropylbenzenesulfonyloxy)-9H-purine
256945-19-4

9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-acetylamino-6-(2',4',6'-triisopropylbenzenesulfonyloxy)-9H-purine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
2: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
3: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
N2-acetyl-7,9-dibenzylguaninium bromide

N2-acetyl-7,9-dibenzylguaninium bromide

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
1.2: NH4OH / 1 h / Heating
2.1: 93 percent / 1-methyl-pyrrolidin-2-one / 1 h / 150 °C
3.1: 1-methyl-pyrrolidin-2-one / 2 h / 120 °C
4.1: HCOONH4 / Pd/C / methanol / 4 h / Heating
5.1: aq. NaOH / 0.5 h / Heating
6.1: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
7.1: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
8.1: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
9.1: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
10.1: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
9-(4-acetoxy-3-acetoxymethyl-butyl)-2-acetylamino-7-benzyl-6-oxo-6,7-dihydro-1H-purin-9-ium; bromide

9-(4-acetoxy-3-acetoxymethyl-butyl)-2-acetylamino-7-benzyl-6-oxo-6,7-dihydro-1H-purin-9-ium; bromide

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: HCOONH4 / Pd/C / methanol / 4 h / Heating
2: aq. NaOH / 0.5 h / Heating
3: 83 percent / 1-methyl-pyrrolidin-2-one / 5 h / 150 °C
4: 99 percent / Et3N; DMAP / CH2Cl2 / 2.5 h / 20 °C
5: 60 percent / H2; Et3N / Pd/C / ethanol / 8 h / 80 - 85 °C / 2250.18 Torr
6: 99 percent / aq. MeNH2 / 0.25 h / 20 °C
7: 97 percent / pyridine; DMAP / tetrahydrofuran / 3 h / 20 °C
View Scheme
3-hydroxymethyl-4-hydroxybutanal diethyl acetal
55387-85-4

3-hydroxymethyl-4-hydroxybutanal diethyl acetal

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: 83 percent / Dowex 50WX8-H(1+) resin / ethanol / 2 h / Heating
2.1: 99 percent / NEt3 / CH2Cl2 / 3 h / 0 - 20 °C
3.1: 47 percent / HCl / H2O; dioxane / 18 h / 20 °C
4.1: 95 percent / NEt3; DMAP; 3 Angstroem molecular sieves / acetonitrile / 1 h / 20 °C
5.1: bis(trimethylsilyl)acetamide / dimethylformamide / 1.5 h / 20 °C
5.2: 81 percent / TMSOTf / dimethylformamide / 3 h / 0 - 5 °C
6.1: 42 percent / aq. NaOH / dioxane / 4 h / 20 °C
7.1: DIBAL-H / tetrahydrofuran / 24 h / 20 °C
8.1: NEt3; DMAP / CH2Cl2 / 2 h / Heating
9.1: 81 percent / hydrogen; NEt3 / Pd/C / ethyl acetate / 4 h / 50 °C / 760 Torr
View Scheme
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

6-deoxypenciclovir
104227-86-3

6-deoxypenciclovir

Conditions
ConditionsYield
With ammonia In methanol for 18h; Ambient temperature;96%
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

benzoyl chloride
98-88-4

benzoyl chloride

C28H27N5O6

C28H27N5O6

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃; for 14h;88%
Ethyl boronic acid
4433-63-0

Ethyl boronic acid

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

9-(4-acetoxy-3-acetoxymethylbutyl)-2-amino-6-ethylpurine
131266-23-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-amino-6-ethylpurine

Conditions
ConditionsYield
With tris(2,2'-bipyridyl)ruthenium dichloride; 1-acetoxy-1,2-benziodoxol-3-one at 30℃; for 4h; Minisci Aromatic Substitution; Inert atmosphere; Irradiation;70%
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

1,3-dioxoisoindolin-2-yl cyclohexanecarboxylate

1,3-dioxoisoindolin-2-yl cyclohexanecarboxylate

2-(2-(2-amino-6-cyclohexyl-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate

2-(2-(2-amino-6-cyclohexyl-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate

Conditions
ConditionsYield
With [4,4’-bis(1,1-dimethylethyl)-2,2’-bipyridine-N1,N1‘]bis [3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-N]phenyl-C]iridium(III) hexafluorophosphate; trifluoroacetic acid In N,N-dimethyl acetamide at 20℃; for 6h; Schlenk technique; Inert atmosphere; Irradiation; regioselective reaction;54%
oct-7-yn-1-ol
871-91-0

oct-7-yn-1-ol

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

C22H31N5O5

C22H31N5O5

Conditions
ConditionsYield
With 4,5,6,7-tetrafluoro-1-hydroxybenzo[d][1,2]iodaoxol-3(1H)-one; Ru(bpy)3Cl2 at 30℃; for 24h; Minisci Aromatic Substitution; Inert atmosphere; Irradiation; regioselective reaction;53%
C8H14BNO3

C8H14BNO3

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

C22H30N6O5

C22H30N6O5

Conditions
ConditionsYield
With tris(2,2'-bipyridyl)ruthenium dichloride; 1-acetoxy-1,2-benziodoxol-3-one at 30℃; for 7h; Minisci Aromatic Substitution; Inert atmosphere; Irradiation;51%
cyclohexylboronic acid
4441-56-9

cyclohexylboronic acid

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

2-(2-(2-amino-6-cyclohexyl-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate

2-(2-(2-amino-6-cyclohexyl-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate

Conditions
ConditionsYield
With tris(2,2'-bipyridyl)ruthenium dichloride; 1-acetoxy-1,2-benziodoxol-3-one at 30℃; for 4h; Minisci Aromatic Substitution; Inert atmosphere; Irradiation;50%
Cyclobutanecarboxylic acid
3721-95-7

Cyclobutanecarboxylic acid

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

C18H25N5O4

C18H25N5O4

Conditions
ConditionsYield
With copper(I) thiophene-2-carboxylate; (4,4'-di-tert-butyl-2,2'-dipyridyl)-bis-(5-methyl-2-(4-fluorophenyl)pyridine(-1H))-iridium(III) hexafluorophosphate; N,N,N′,N′-tetramethyl-N″-tert-butylguanidine; bathophenanthroline; iodomesitylene diacetate In 1,4-dioxane at 20℃; for 1h; Inert atmosphere; Irradiation; regioselective reaction;40%
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

(R,S)-9-<4-acetoxy-3-(hydroxymethyl)but-1-yl>-2-aminopurine
120687-07-2

(R,S)-9-<4-acetoxy-3-(hydroxymethyl)but-1-yl>-2-aminopurine

Conditions
ConditionsYield
With potassium carbonate In methanol for 0.333333h;30%
With esterase from Escherichia coli host strain; oxygen In dimethyl sulfoxide at 30℃; pH=7.4; Enzymatic reaction;
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

A

9-(4-acetoxy-3-hydroxymethyl-1-yl)-2-aminopurine

9-(4-acetoxy-3-hydroxymethyl-1-yl)-2-aminopurine

B

(R,S)-9-<4-acetoxy-3-(hydroxymethyl)but-1-yl>-2-aminopurine
120687-07-2

(R,S)-9-<4-acetoxy-3-(hydroxymethyl)but-1-yl>-2-aminopurine

Conditions
ConditionsYield
With potassium carbonate In methanol; acetic acidA n/a
B 30%
9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine
104227-87-4

9-(4-acetoxy-3-acetoxymethylbutyl)-2-aminopurine

Penciclovir
39809-25-1

Penciclovir

Conditions
ConditionsYield
With oxygen In water for 2.5h; cows' milk xanthine oxidase, pH 7; Yield given;

Famciclovir Specification

1. Introduction of Famciclovir

Famciclovir, with the IUPAC Name of [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate, is one kind of  Off-White Powder. And this chemical belongs to the Product Categories which include Intermediates; Intermediates & Fine Chemicals; Pharmaceuticals; API's.

2. Properties of Famciclovir

Famciclovir has the following datas: (1)Melting Point: 102-104°C; (2)Boiling point: 550.2 °C at 760 mmHg; (3)Flash Point: 286.6 °C; (4)Density: 1.4 g/cm3; (5)Index of Refraction: 1.628; (6)Molar Refractivity: 81.11 cm3; (7)Molar Volume: 228.4 cm3; (8)Surface Tension: 54.3 dyne/cm; (9)Enthalpy of Vaporization: 83.02 kJ/mol; (10)Vapour Pressure: 3.73E-12 mmHg at 25°C.

3. Structure Descriptors of Famciclovir

(1). Canonical SMILES: CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
(2). InChI: InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18) 
(3). InChIKey: GGXKWVWZWMLJEH-UHFFFAOYSA-N

4. Use of Famciclovir

Famciclovir is a guanine analogue antiviral drug and it's used for the treatment of various herpesvirus infections, especial for herpes zoster (shingles). Famciclovir comes as a tablet to take by mouth. It is usually taken every three times a day for 7 days to treat shingles. If it's used to treat genital herpes, famciclovir is usually taken twice a day for 5 days. It is also sometimes given in one single large dose as opposed to several days of scheduled small doses. Take famciclovir with food or milk.

5. Safety information of Famciclovir

Safety Information of Famciclovir (CAS NO.104227-87-4):
Hazard Codes: TToxic
Risk Statements: 20/21/22-45-61  
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed. 
R45:May cause cancer. 
R61:May cause harm to the unborn child.
Safety Statements: 36/37/39-45-53
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S53:Avoid exposure - obtain special instructions before use.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View